Diabetes is a major cause of death 1 in developed countries, and the problem is getting worse.
Diabetes arises when the body cannot produce enough insulin (type 1 diabetes) or when the body produces insulin but cannot use it properly (type 2 diabetes).1 Both conditions are serious and require careful monitoring and control.
Diabetes is a growing global health threat and the 7th biggest cause of death in humans, with an estimated 425 2 million people worldwide suffering from diabetes. Diabetes is now the fourth leading cause of death in most developed countries. Each year, more than three million deaths worldwide are due to diabetes-related causes.
Read more
- NICE guideline ph38: Type 2 diabetes: prevention in people at high risk. Published 12 July 2012. Available at: https://www.nice.org.uk/guidance/ph38/chapter/8-glossary#pre-diabetes. Last accessed March 2018.
- ADA (American Diabetes Association). Standards of Medical Care in Diabetes. Diabetes Care. 2013;36(1):S11 66.
- IDF (International Diabetes Federation). (2012). Clinical Guidelines Task Force: Global guideline for the management of type 2 diabetes. Available at: https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes Last accessed March 2018.
- DPP Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346:393 403.
- ESC (European Society of Cardiology). Diabetes, Prediabetes and Cardiovascular Diseases with the EASD. Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Diabetes-Pre-Diabetes-and-Cardiovascular-Diseases-developed-with-the-EASD. Last accessed November 2017
- SMC. UK 2017. Glucophage SR 500mg, 750mg and 1000mg prolonged release tablets.